NikoleV Posted February 15, 2013 Share Posted February 15, 2013 Dr. Suresh Ramalingam Reviews the “Phases” of Clinical Research Trials and Trial Development January 21st, 2013 - by Dr. Jack West http://expertblog.lungevity.org/2013/01 ... s-1-and-2/ Recently, we had the privilege of featuring my friend, Dr. Suresh Ramalingam, who is the current Chair of the Lung Cancer Committee for the Eastern Cooperative Oncology Group (ECOG) as well as Professor and Chair of Medical Oncology at Emory University’s Winship Cancer Center, speaking in a webinar on the integral topic of clinical trials in cancer. He’s a great person to cover this area, because he has not only shepherded his own patients through important clinical trials, but he has also written many new studies that are shaping how we treat lung cancer now, and they have also identified promising directions for future therapies. As chair of ECOG’s Lung Cancer Committee, his guidance shapes the national priorities for lung cancer research, as ECOG studies are conducted at dozens of research centers across the US and emerge as landmarks in our understanding of cancer and the best treatments for it. Here is the first part of his presentation, with video and audio versions of this podcast, along with the transcript and figures. (Click on the link above to view the podcast and transcript links) Ramalingam Clin Research in Cancer Pt 1 Video Podcast Ramalingam Clin Research in Cancer Pt 1 Audio Podcast Ramalingam Clin Research in Cancer Pt 1 Transcript Ramalingam Clin Research in Cancer Pt 1 Figures Part 2 of his presentation reviewed how we develop everything from the basic premise of what the trial will test, how we develop the statistical tests, trial documentation, and the regulatory requirements leading to a clinical trial becoming available for patient enrollment at an institution. (Click on the link above to view the podcast & transcript links) Ramalingam Clin Research Pt 2 Video Podcast Ramalingam Clin Research Pt 2 Audio Podcast Ramalingam Clin Research Pt 2 Transcript Ramalingam Clin Research Pt 2 Figs Part 3 will discuss a series of common myths and facts about clinical trials, as well as a discussion of patient rights for the people who enroll in trials. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.